VENUS REMEDIES
|
VENUS REMEDIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹134 Cr | ₹62 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr |
| Adjustment | ₹18 Cr | ₹17 Cr | ₹20 Cr | ₹23 Cr | ₹26 Cr |
| Changes In working Capital | ₹38 Cr | ₹22 Cr | ₹-12 Cr | ₹-25 Cr | ₹-22 Cr |
| Cash Flow after changes in Working Capital | ₹190 Cr | ₹101 Cr | ₹53 Cr | ₹37 Cr | ₹41 Cr |
| Cash Flow from Operating Activities | ₹156 Cr | ₹86 Cr | ₹37 Cr | ₹37 Cr | ₹41 Cr |
| Cash Flow from Investing Activities | ₹-182 Cr | ₹-76 Cr | ₹-7.21 Cr | ₹-51 Cr | ₹-17 Cr |
| Cash Flow from Financing Activities | ₹-3.12 Cr | ₹-1.02 Cr | ₹-1.08 Cr | ₹-0.57 Cr | ₹-9.48 Cr |
| Net Cash Inflow / Outflow | ₹-29 Cr | ₹9.18 Cr | ₹29 Cr | ₹-15 Cr | ₹15 Cr |
| Opening Cash & Cash Equivalents | ₹58 Cr | ₹49 Cr | ₹21 Cr | ₹43 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-3.50 Cr | ₹-0.61 Cr | ₹-1.25 Cr | ₹-7.27 Cr | ₹-0.52 Cr |
| Closing Cash & Cash Equivalent | ₹25 Cr | ₹58 Cr | ₹49 Cr | ₹21 Cr | ₹43 Cr |
Compare Cashflow Statement of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,423.3 Cr | 9.1% | 4.9% | 271.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 9.1% |
4.9% |
271.5% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses